The US peptide market in 2026
The United States accounts for an estimated 60–70% of all peptide ecommerce revenue globally. It is the most mature, most competitive, and most lucrative market for a US-based peptide brand to operate in. It is also the most scrutinised — by ad platforms, payment processors, and federal regulators alike.
For a peptide brand starting today, the US is unambiguously the right home market. Customer willingness to pay is high, average order values run from $150 to $400, and lifetime values frequently exceed $2,500 for brands with disciplined retention. Almost every peptide brand we work with — whether the company is registered in Wyoming, Delaware, or Florida — derives the majority of its revenue from US customers.
What makes US peptide marketing different from generalist US ecommerce marketing is not the audience — it is the constraint surface. The audience itself is research-led, technically literate, and arrives via channels that look nothing like a traditional DTC funnel. Reddit, niche forums, peptide-specific Discord servers, podcast appearances, and YouTube long-form content drive a disproportionate share of US peptide brand awareness compared to Meta and Google paid alone.
Cities and hubs
Miami has become the centre of gravity for US peptide ecommerce. A large share of our managed US brands have founder presence in Miami or South Florida. The combination of favourable tax structure, fitness-and-wellness adjacency, and dense founder community has made it the de facto industry hub.
Austin is the second strongest city by founder concentration, particularly for brands skewing biohacker and longevity-adjacent. We work with several Austin-based peptide brands across this category.
Los Angeles dominates for brands with celebrity or influencer overlap. New York remains important for premium-positioned brands and brands targeting the financial wellness customer. Scottsdale and Nashville have meaningful but smaller scenes.
Compliance landscape
Most US peptide ecommerce brands operate under the Research Use Only (RUO) framework. RUO products are sold strictly for laboratory research rather than human consumption. The labelling, claims language, and creative inventory available to an RUO brand is materially different from a supplement brand — and getting this wrong on ad creative is the most common reason peptide ad accounts get banned.
US-specific factors to be aware of: state-level variation matters (California has been the most aggressive on enforcement), the FTC pays attention to claims language, and the FDA maintains a watchlist of brands making outright human-consumption claims. None of this prevents marketing — it shapes how marketing has to be done.
Ad platforms enforce US policy more strictly than international policy in some categories and more loosely in others. Meta is the most volatile. Google paid search is the most permissive when configured correctly. TikTok varies by quarter.
Payment processors and chargebacks
Standard consumer processors — Stripe, PayPal, Square — almost universally classify peptide merchants as high-risk and will terminate accounts that breach informal chargeback thresholds. Most established US peptide brands route payments through a curated short list of high-risk processors that approve the vertical.
Keeping the chargeback rate below 1% is non-negotiable for retaining processor relationships. The retention systems we build for US brands explicitly include chargeback-prevention workflows — pre-shipping notifications, transparent product expectations on the PDP, and refund flows that intercept disputes before they reach the issuing bank.
What we do for US peptide brands
Our US engagements typically combine paid media across Google, Meta, TikTok, and increasingly Reddit; email retention calibrated to US-typical 30–45 day reorder cycles; web and ecommerce built for high AOVs and bulk purchase patterns; and strategy and CRO.
Two patterns have emerged from running engagements across 30+ US brands. First, the brands that win at scale do so on the back of email and SMS — not paid acquisition. Paid is for fuel; retention is for compounding. Second, US peptide brands consistently under-invest in PDP and PLP quality. The fastest-rising brands in our managed book have all rebuilt their product pages in the past 18 months.
Working with us
Engagements with US-based peptide brands begin with a free 45-minute discovery call. We review your current marketing, account structure, and growth goals, then propose a scope. Most clients start within two weeks.
Peptide marketing — other regions